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1. Introduction
The function of medical physicist is 3d treatment planning in
endobronchial brachytherapy. This process consists in deter-
mining delivery parameters such as time and position of the
source in order to treat CTV preserving normal tissue and
OARs. In our hospital, this technique is performed with high
dose rate source (iridium 192).
2. Material and method
After placing a ﬂexible plastic catheter in the patient, scan
CT is performed, slice thickness is 3mm. The scan used is
Picker PQS helical scanner (Philips Medical Systems). Before
acquiring CT images, radiopaque guide is placed inside the
catheter. This guide allows us to locate catheter in the vir-
tual simulation. These CT images are transferred to planning
system Oncentra release 4.1 (Nucletron). Here, Target volume
and organs at risk are drawn on CT slices by radiation oncol-
ogist and neumologist.
The ﬁrst step in the planning is to building the catheter.
Next step, activate the points where the source will stop.
These stops are usually separated 2.5 cm. It is important at this
point to have an accurate measurement of the offset distance
between the tip of the catheter and the ﬁrst dwell position
available.
After,weprescribe andoptimize onpoints generatedon the
target dose. The histogram and isodoses curves are evaluated
by the radiation oncologist.
Finally, when the plan is approved, it is transferred and
delivered by nucletron microselectron afterloader system.
Treatment typically lasts 2–5min, depending on the dose
delivered and the source activity. After treatment is complete,
the radioactive source is automatically withdrawn and the
catheter is removed.
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